Pier Capital’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Pier Capital’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-195,653	Closed	-$12.2M	–	132
2023 Q4	$12.2M	Buy	195,653 +114,741	+142%	+$2.85M	1.74%	4
2023 Q3	$1.8M	Buy	+80,912	New	+$1.7M	0.29%	93

Pier Capital's RYZB Position: Q1 2024 in Review

Pier Capital sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 195,653 shares — an estimated $12.2M sold.

Pier Capital first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $12.2M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Pier Capital reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Pier Capital sold 195,653 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $12.2M.
Pier Capital first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Pier Capital's RayzeBio, Inc. Common Stock position peaked at $12.2M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Pier Capital's 13F filing for Q1 2024, filed 3 May 2024.